Bachmann’s Bundle Modification in Addition to Circumferential Pulmonary Vein Isolation for Atrial Fibrillation: A Novel Ablation Strategy

Table 4

Procedure results and clinical outcomes of patients with paroxysmal AF after propensity score matching.

	Total (n = 82)	CPVI (n = 41)	CPVI-BB (n = 41)	value
Ablation time	77.28 ± 22.52	74.76 ± 22.20	79.80 ± 22.83	0.313
Procedure-related complications	1 (2.4%)	0	1 (2.4%)	1.000
Clinical outcomes
Clinical recurrence	14 (17.1%)	8 (19.5%)	6 (14.6%)	0.557
AFL or AT recurrence	1 (1.2%)	1 (1.2%)	0	1.00
Early recurrence	14 (17.1%)	7 (17.1%)	7 (17.1%)	1.000
AAD after blanking period	13 (15.9%)	8 (19.5%)	5 (12.2%)	0.364

Values are reported as mean ± standard deviation or n (%). AF: atrial fibrillation; AFL: atrial flutter; AT: atrial tachyarrhythmias; AAD: antiarrhythmic drugs.